Taronis completes sterilisation of cyanobacteria in Hibiscus Lake, Florida

American clean technology company Taronis Technologies has completed a commercial pilot for its water decontamination technology for the remediation of cyanobacteria.

The company provides technology solutions for the renewable resources and environmental conservation industry.

The pilot project involved the treatment of a cyanobacteria blue-green algae bloom at Hibiscus Lake in Clearwater, Florida.

The city of Clearwater approved the contract and the work was completed last week.

Even though the initial findings indicate that cyanobacteria levels have dramatically reduced after the treatment and the algae bloom was remediated, the company said that it will conduct testing and monitoring for several weeks.

Taronis CEO Scott Mahoney said: “This was a positive milestone for our emerging water technology applications. We gathered a great deal of critical data related to the efficacy of our solution, as well as the economic viability of a commercially scalable version of our current mobile water decontamination plasma arc demonstration unit.”

The company’s plasma arc technology enables two end-use applications for fuel generation and water decontamination.

Its fuel technology enables the conversion of hydrocarbon feedstocks to fossil fuel substitutes.

Taronis is developing a range of end market uses for these fuels, such as replacement products for propane, compressed natural gas (CNG) and liquefied natural gas (LNG).

The company said that its technology can also be used for the decontamination of wastewater, including sterilising water, eradicating pathogens.

Its technology process can also reduce or eliminate other contaminants, such as harmful metals, nitrogen, phosphorus and potassium levels that trigger toxic algae blooms.

Mahoney said: “With this successful pilot, we plan to now shift our focus to seek out a potential commercial partner with whom we would look to introduce this solution at a larger scale.

“We have identified several promising potential partners with a strong strategic fit with our vision for a combined solution.

“Our goal is to identify a joint venture or licensing arrangement as soon as practically possible for our cyanobacteria solution.”

The company has operations at 22 locations across California, Texas, Louisiana and Florida.